Entering text into the input field will update the search result below

CareDx's partner Cibiltech begins trial of iBox AI to monitor kidney transplant patients

Mar. 03, 2022 8:56 AM ETCareDx, Inc (CDNA)By: Ravikash, SA News Editor

Scientists working together on a research

Luis Alvarez/DigitalVision via Getty Images

  • CareDx (NASDAQ:CDNA) said its French strategic partner Cibiltech began the CIBIL clinical trial to evaluate the performance of iBox artificial intelligence (AI) as a prognostic measure of organ survival in kidney transplant patients.
  • The

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.